Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Olanzapine/quetiapine

Olanzapine/quetiapine Reactions 1680, p266 - 2 Dec 2017 Weight gain and fatigue: case report A 26-year old woman developed weight gain and fatigue during treatment with olanzapine and quetiapine. The woman, who was diagnosed with visual hallucinations, was started on olanzapine and quetiapine 50 mg/day (maximum dose) for 4 months [routes not stated and not all dosages stated]. She developed worrisome weight gain and fatigue [time to reactions onsets not stated] and her therapy with olanzapine and quetiapine was discontinued [outcomes not stated]. Author comment: "She had tried treatment with antipsychotic quetiapine (maximal dose 50 mg per day) for 4 months and with olanzapine (maximal dose and duration of use unknown). Both treatments were discontinued as she experienced bothersome side effects (weight gain and fatigue)". Koops S, et al. Transcranial direct current stimulation (tDCS) as a treatment for visual hallucinations: A case study. Psychiatry Research 258: 616-617, Dec 2017. Available from: URL: http://doi.org/10.1016/j.psychres.2017.03.054 - Netherlands 803284733 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Olanzapine/quetiapine

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Download PDF
1 page

Olanzapine/quetiapine

Abstract

Reactions 1680, p266 - 2 Dec 2017 Weight gain and fatigue: case report A 26-year old woman developed weight gain and fatigue during treatment with olanzapine and quetiapine. The woman, who was diagnosed with visual hallucinations, was started on olanzapine and quetiapine 50 mg/day (maximum dose) for 4 months [routes not stated and not all dosages stated]. She developed worrisome weight gain and fatigue [time to reactions onsets not stated] and her therapy with olanzapine and quetiapine was...
Loading next page...
 
/lp/springer_journal/olanzapine-quetiapine-z9DlW7QyDM

References (1)

Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
DOI
10.1007/s40278-017-39197-0
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p266 - 2 Dec 2017 Weight gain and fatigue: case report A 26-year old woman developed weight gain and fatigue during treatment with olanzapine and quetiapine. The woman, who was diagnosed with visual hallucinations, was started on olanzapine and quetiapine 50 mg/day (maximum dose) for 4 months [routes not stated and not all dosages stated]. She developed worrisome weight gain and fatigue [time to reactions onsets not stated] and her therapy with olanzapine and quetiapine was discontinued [outcomes not stated]. Author comment: "She had tried treatment with antipsychotic quetiapine (maximal dose 50 mg per day) for 4 months and with olanzapine (maximal dose and duration of use unknown). Both treatments were discontinued as she experienced bothersome side effects (weight gain and fatigue)". Koops S, et al. Transcranial direct current stimulation (tDCS) as a treatment for visual hallucinations: A case study. Psychiatry Research 258: 616-617, Dec 2017. Available from: URL: http://doi.org/10.1016/j.psychres.2017.03.054 - Netherlands 803284733 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions Weekly – Springer Journals

Published: Dec 2, 2017

There are no references for this article.